Is a complete PRAX research report available?

No complete published report is available for Praxis Precision Medicines, Inc. (PRAX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Praxis Precision Medicines, Inc. (PRAX)

NASDAQ: PRAX · USD

$325

+2.90 (+0.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PRAX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.1B
Net income (ttm)	-326.5M
EPS (ttm)	-$13.3
Shares out	27.9M
Volume	282,678
Beta	2.76
Price target	$610	+87.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -326.5M
EPS (ttm): -$13.3
Market cap: 9.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PRAX indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001689548
Company name	Praxis Precision Medicines, Inc.
Country	United States
Country code	US
Cusip	74006W207
Employees	168
Employees Change	52%
Employees Change Percent	44.83
Enterprise value	$7.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-10-16
Isin	US74006W2070
Last refreshed	2026-07-27
Market cap	$9.1B
Market cap category	Mid-Cap
Price	$325
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2834
Symbol	PRAX
Website	https://praxismedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.6%
EV Sales Forward	388.7x
FCF yield	-3.11%
P/B ratio	6.43x
PS Forward	462.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-284.3M
Net Income	$-326.5M
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-23.04
Roa5y	-50.19
ROCE	-25.34
ROE	-35.32
Roe5y	-95.79
ROIC	-24.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	470.48%
Cagr3y	171.74%
Cagr5y	5.76%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$1.5B
Cash	$786.9M
Current Assets	$797.8M
Current Liabilities	$50.2M
Debt	$1.4M
Debt Equity	$0
Equity	$1.4B
Liabilities	$50.2M
Long Term Assets	$662.4M
Long Term Liabilities	$0
Net Cash	$1.4B
Net Cash By Market Cap	$15.95
Net Cash Growth	207.11%
Net Debt Equity	$-1.03
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$50.61
WACC	19.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.88
Net Working Capital	$-37.9M
Quick ratio	15.66
Working Capital	$747.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.2%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	469.8%
200-day SMA	278.2
3Y total return	1,908.03%
50-day SMA	310.6
50-day SMA vs 200-day SMA	50over200
5Y total return	32.32%
All Time High	914.3
All Time High Change	-64.42%
All Time High Date	2021-01-08
All Time Low	11.85
All Time Low Change	2,645.15%
All Time Low Date	2023-03-31
ATR	18.83
Beta	2.76
Beta1y	3.86
Beta2y	2.12
Ch YTD	10.37
High	327.5
High52	366.5
High52 Date	2026-05-27
High52ch	-11.25%
Low	314.6
Low52	37.19
Low52 Date	2025-09-08
Low52ch	774.7%
Ma50ch	4.73%
Price vs 200-day SMA	16.94%
RSI	54.4
RSI Monthly	73.81
RSI Weekly	56.57
Sharpe ratio	1.4x
Sortino ratio	6.1
Total Return	-24.2%
Tr YTD	10.37
Tr1m	6.53%
Tr1w	3.46%
Tr3m	-1.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Count Top	15
Analyst Price Target Top	$631
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-3.67
Operating Income	$-357.3M
Price target	$610
Price Target Change	$87.54
Price Target Change Top	$94.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,035,271%
Float Percent	86.21%
Shares Insiders	0.19%
Shares Institutions	101.8%
Shares Out	27,878,774
Shares Qo Q	13.68%
Shares Yo Y	24.2%
Short Float	16.59%
Short Ratio	6.32
Short Shares	14.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-324.6M
Average Volume	469,950.95x
Bv Per Share	50.61
CAPEX	$-118,000
Ch1m	6.53
Ch1w	3.46
Ch1y	469.8
Ch3m	-1.3
Ch3y	1,908
Ch5y	32.32
Ch6m	4.36
Change	0.9%
Change From Open	0.93
Close	322.4
Days Gap	-0.03
Depreciation Amortization	132,000
Dollar Volume	91,955,153.4
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-357.3M
EBITDA	$-357.2M
EPS	$-13.35
F Score	2
FCF	$-282.3M
FCF EV Yield	-3.7x
FCF Per Share	$-10.13
Financing CF	1,257,335,000
Fiscal Year End	December
Founded	2,015
Investing CF	-604,359,000
Ipr	1,612.1
Iprfo	-16.4
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2023-11-29
Last Split Type	Reverse
Last10k Filing Date	2026-02-19
Ma150	311.6
Ma150ch	4.41%
Ma20	322.3
Ma20ch	0.94%
Net CF	370,766,000
Next Earnings Date	2026-08-07
Open	322.3
Optionable	Yes
Position In Range	82.85
Post Close	325.3
Postmarket Change Percent	0.22
Postmarket Price	$326
Ppne	1,490,000
Price Date	2026-07-24
Ptbv Ratio	6.43
Relative Volume	0.6x
Share Based Comp	42,267,000
Tr6m	4.36%
Us State	Massachusetts
Volume	282,678

Praxis Precision Medicines, Inc. (PRAX)

Coverage state: Market snapshot only — no published research

Generate the first PRAX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PRAX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PRAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PRAX

Frequently asked questions